Kingswood Wealth Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,690
Closed -$10.1K 726
2024
Q4
$10.1K Buy
+18,690
New +$10.1K ﹤0.01% 781